Literature DB >> 23963836

Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia.

Caterina P Minniti1, Kara-Marie H Delaney, Alexander M Gorbach, Dihua Xu, Chyi-Chia Richard Lee, Nitin Malik, Antony Koroulakis, Matthew Antalek, Jordan Maivelett, Marlene Peters-Lawrence, Enrico M Novelli, Sophie M Lanzkron, Karen C Axelrod, Gregory J Kato.   

Abstract

Chronic leg ulcers are frequent and debilitating complications of sickle cell anemia. Inadequate blood supply has been postulated to be an important factor in their occurrence and delayed healing. Little is known about their microcirculatory and histopathological changes. We evaluated the microcirculation of lower extremity ulcers with laser speckle contrast imaging and infrared thermography and obtained clinical and laboratory characteristics in 18 adults with sickle cell anemia and chronic leg ulcers. Skin biopsies were obtained in four subjects. Subjects had markers of severe disease, anemia, high degree of hemolysis, inflammation, and thrombophilia. The highest blood flow was present in the ulcer bed, progressively less in the immediate periwound area, and an unaffected control skin area in the same extremity. Microscopic examination showed evidence of venostasis, inflammation, and vasculopathy. Blood vessels were increased in number, had activated endothelium and evidence of thrombosis/recanalization. High blood flow may be due to chronic inflammation, cutaneous vasodilatation, venostasis, and in situ thrombosis. These changes in skin microcirculation are similar to chronic venous ulcers in the non-sickle cell disease (SCD) population, thus suggesting that leg ulcers may be another end-organ complication with endothelial dysfunction that appears in patients with SCD at a younger age and with higher frequency than in the general population.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23963836      PMCID: PMC3946883          DOI: 10.1002/ajh.23571

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  41 in total

Review 1.  Cutaneous wound healing.

Authors:  A J Singer; R A Clark
Journal:  N Engl J Med       Date:  1999-09-02       Impact factor: 91.245

2.  Laboratory and echocardiography markers in sickle cell patients with leg ulcers.

Authors:  Caterina P Minniti; James G Taylor; Mariana Hildesheim; Patricia O'Neal; Jonathan Wilson; Oswaldo Castro; Victor R Gordeuk; Gregory J Kato
Journal:  Am J Hematol       Date:  2011-05-31       Impact factor: 10.047

3.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

4.  Blood hypercoagulability as a risk factor for leg ulcers in sickle cell disease.

Authors:  E Cacciola; R Musso; R Giustolisi; E Cacciola; M Alessi
Journal:  Blood       Date:  1990-06-15       Impact factor: 22.113

5.  Venous insufficiency is not the cause of leg ulcers in sickle cell disease.

Authors:  H H Billett; Y Patel; S P Rivers
Journal:  Am J Hematol       Date:  1991-06       Impact factor: 10.047

6.  In vivo laser speckle imaging reveals microvascular remodeling and hemodynamic changes during wound healing angiogenesis.

Authors:  Abhishek Rege; Nitish V Thakor; Kevin Rhie; Arvind P Pathak
Journal:  Angiogenesis       Date:  2011-12-24       Impact factor: 9.596

7.  Abnormalities of coagulation and fibrinolysis in homozygous sickle cell disease.

Authors:  B Nsiri; N Gritli; F Bayoudh; T Messaoud; S Fattoum; S Machghoul
Journal:  Hematol Cell Ther       Date:  1996-07

8.  Long-term stroke risk in children with sickle cell disease screened with transcranial Doppler.

Authors:  R J Adams; V C McKie; E M Carl; F T Nichols; R Perry; K Brock; K McKie; R Figueroa; M Litaker; S Weiner; D Brambilla
Journal:  Ann Neurol       Date:  1997-11       Impact factor: 10.422

Review 9.  Leg ulcers in sickle cell disease.

Authors:  J R Eckman
Journal:  Hematol Oncol Clin North Am       Date:  1996-12       Impact factor: 3.722

10.  Venous incompetence, poverty and lactate dehydrogenase in Jamaica are important predictors of leg ulceration in sickle cell anaemia.

Authors:  V Cumming; L King; R Fraser; G Serjeant; M Reid
Journal:  Br J Haematol       Date:  2008-05-08       Impact factor: 6.998

View more
  24 in total

1.  Vancomycin-induced linear IgA bullous dermatosis.

Authors:  Claire J Wiggins; Susan Y Chon
Journal:  Proc (Bayl Univ Med Cent)       Date:  2020-08-26

2.  Topical fentanyl stimulates healing of ischemic wounds in diabetic rats.

Authors:  Mihir Gupta; Tasneem Poonawala; Mariya Farooqui; Marna E Ericson; Kalpna Gupta
Journal:  J Diabetes       Date:  2015-01-15       Impact factor: 4.006

3.  RX of sickle cell leg ulcers.

Authors:  Simeon Pollack
Journal:  Int Wound J       Date:  2016-03-28       Impact factor: 3.315

4.  Retinal oximetry and fractal analysis of capillary maps in sickle cell disease patients and matched healthy volunteers.

Authors:  W A J Birkhoff; L van Manen; J Dijkstra; M L De Kam; J C van Meurs; A F Cohen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-09-16       Impact factor: 3.117

5.  Intima-media thickness of the common femoral artery as a marker of leg ulceration in sickle cell disease patients.

Authors:  Oluwagbemiga O Ayoola; Rahman A Bolarinwa; Uvie U Onakpoya; Tewogbade A Adedeji; Chidiogo C Onwuka; Bukunmi M Idowu
Journal:  Blood Adv       Date:  2018-11-27

6.  Nitric Oxide-Independent Soluble Guanylate Cyclase Activation Improves Vascular Function and Cardiac Remodeling in Sickle Cell Disease.

Authors:  Karin P Potoka; Katherine C Wood; Jeffrey J Baust; Marta Bueno; Scott A Hahn; Rebecca R Vanderpool; Tim Bachman; Grace M Mallampalli; David O Osei-Hwedieh; Valerie Schrott; Bin Sun; Grant C Bullock; Eva-Maria Becker-Pelster; Matthias Wittwer; Jan Stampfuss; Ilka Mathar; Johannes-Peter Stasch; Hubert Truebel; Peter Sandner; Ana L Mora; Adam C Straub; Mark T Gladwin
Journal:  Am J Respir Cell Mol Biol       Date:  2018-05       Impact factor: 6.914

7.  Inflammation in sickle cell disease.

Authors:  Nicola Conran; John D Belcher
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375

8.  High levels of proinflammatory cytokines IL-6 and IL-8 are associated with a poor clinical outcome in sickle cell anemia.

Authors:  Igor F Domingos; Diego A Pereira-Martins; Marcondes J V C Sobreira; Romulo T D Oliveira; Adekunle E Alagbe; Carolina Lanaro; Dulcineia M Albuquerque; Maria H S L Blotta; Aderson S Araujo; Fernando F Costa; Antonio R Lucena-Araujo; Maria F Sonati; Marcos A C Bezerra; Magnun N N Santos
Journal:  Ann Hematol       Date:  2020-03-05       Impact factor: 3.673

Review 9.  A treatment algorithm to identify therapeutic approaches for leg ulcers in patients with sickle cell disease.

Authors:  Igor A Altman; Raymond E Kleinfelder; John G Quigley; William J Ennis; Caterina P Minniti
Journal:  Int Wound J       Date:  2015-11-04       Impact factor: 3.315

10.  Iron Chelation with Transdermal Deferoxamine Accelerates Healing of Murine Sickle Cell Ulcers.

Authors:  Melanie Rodrigues; Clark A Bonham; Caterina P Minniti; Kalpna Gupta; Michael T Longaker; Geoffrey C Gurtner
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-10-11       Impact factor: 4.730

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.